Results 31 to 40 of about 78,612 (185)

Atherosclerotic plaque rupture – pathologic basis of plaque stability and instability [PDF]

open access: yesCardiovascular Research, 1999
Time for primary reveiw 27 days Atherosclerosis continues to be one of the main subjects in pathology research. The intriguing complexity of its pathogenesis as well as the importance of its clinical sequelae provide a rationale for this [1]. A large number of diseases with totally different clinical presentations are basically atherosclerosis ...
A C, van der Wal, A E, Becker
openaire   +4 more sources

Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis

open access: yesFrontiers in Neurology, 2021
We aimed to study the clinical utility of serum lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute ischemic stroke (AIS) with cerebral artery stenosis (CAS). We included 200 AIS patients and 90 healthy controls in this study.
Jing Cao   +5 more
doaj   +1 more source

Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Ldlr−/− mice

open access: yesFrontiers in Cardiovascular Medicine, 2023
Background and aimsNeutrophils drive atheroprogression and directly contribute to plaque instability. We recently identified signal transducer and activator of transcription 4 (STAT4) as a critical component for bacterial host defense in neutrophils. The
W. Coles Keeter   +10 more
doaj   +1 more source

Ultra-short echo time cardiovascular magnetic resonance of atherosclerotic carotid plaque [PDF]

open access: yes, 2010
Background Multi-contrast weighted cardiovascular magnetic resonance (CMR) allows detailed plaque characterisation and assessment of plaque vulnerability.
Sonia Nielles-Vallespin   +31 more
core   +1 more source

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis

open access: yesCells, 2019
The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release ...
Eva Kritikou   +13 more
doaj   +1 more source

Plaque stability and plaque regression: new insights [PDF]

open access: yesEuropean Heart Journal Supplements, 2006
Patients with prior cardiovascular disease and/or diabetes are at the highest risk of a myocardial infarction or stroke. Thus, the majority of morbid cardiovascular events arise in the large population of patients with qualifying risk factors, according to standard risk factor scoring techniques.
Diethelm Tschoepe, Bernd Stratmann
openaire   +1 more source

High Zn content of Randall's plaque: A μ-X-ray fluorescence investigation [PDF]

open access: yes, 2011
Kidney stone disease, or nephrolithiasis, is a common ailment. Among the different risk factors usually associated with nephrolithiasis are dehydration, metabolic defects (especially with regard to calcium and oxalate).
Dominique Bazin   +15 more
core   +1 more source

Klotho protects against chronic kidney disease-associated atherosclerotic plaque vulnerability in

open access: yesDi-san junyi daxue xuebao, 2020
Objective To explore the effects of chronic kidney disease (CKD) on the instability of atherosclerotic plaques and investigate the role of Klotho in this pathological process.
BI Xianjin   +4 more
doaj   +1 more source

Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. [PDF]

open access: yes, 2009
Atherosclerosis is the primary cause of coronary artery disease (CAD). There is increasing recognition that lesion composition rather than size determines the acute complications of atherosclerotic disease.
Lebherz Corinna   +51 more
core   +1 more source

How to stabilize unstable plaque [PDF]

open access: yesCardiovascular Research, 2011
This editorial refers to ‘Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I’ by G.J. Reimers et al. , doi:10.1093/cvr/cvr057 Association studies and epidemiological observations have shown that high plasma levels of high-density lipoprotein-cholesterol (HDL-C) provide cardiovascular protection.1 The ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy